论文部分内容阅读
目的:探讨短程三联疗法治疗幽门螺杆菌(Hp)感染的经济学效果。方法:选择153例经证实为Hp感染患者随机分为A、B、C3组,分别给予奥美拉唑+甲硝唑+阿莫西林,奥美拉唑+甲硝唑+克拉霉素和奥美拉唑+替硝唑+克拉霉素。分别对3种治疗方案进行费用-效果分析。结果:在A、B、C3种方案中,Hp根治率分别为76.92％、90.20％和92.0％。A组费用虽低,但疗效较差,B、C组费用虽高,但根治率亦高。结论:3种方案以C组方案为优。
Objective: To explore the economic effect of short-term triple therapy in the treatment of Helicobacter pylori (Hp) infection. Methods: A total of 153 patients with confirmed Hp infection were randomly divided into A, B, and C3 groups, and were given omeprazole, metronidazole, amoxicillin, omeprazole, metronidazole, clarithromycin, Melazole + tinidazole + clarithromycin. Cost-effectiveness analysis of the three treatment options respectively. Results: The cure rates of Hp in A, B and C3 regimens were 76.92%, 90.20% and 92.0% respectively. A group of fees are low, but the curative effect is poor, B, C group costs high, but the cure rate is also high. Conclusion: Three kinds of programs are excellent in group C.